Chloe Gui

@UofTNeuroSurge resident

[Chloe Gui @chloegui_]

Excited to share our paper published in @TheLancetOncology showing #TERT expression (independent of mutation) is associated with earlier recurrence in #meningiomas. Thank you to my supervisors @GelarehZadeh @FarshadNassiri, coauthors, editors, reviewers https://t.co/bRlxwDdl2c

[Nir Lipsman @DrNirLipsman]

Very special night for @UofTNeuroSurge celebrating the graduation of Justin Wang and Laureen Hachem. It has been a privilege to watch them grow into exceptional surgeons, physicians, scientists. We are incredibly proud and excited to see the impact youll have in the years ahead!

[Alex Landry @ap_landry]

New study out in @LancetDigitalH, demonstrating the utility of #AI for molecular profiling of meningioma with histology images alone

https://t.co/p1PCVX4TKp

@UHN @KBI_UHN @PMResearch_UHN @UofTSurgery @MayoClinic @MayoClinicNeuro

[University of Toronto Neurosurgery @UofTNeuroSurge]

We are excited to introduce you to our seven outstanding individuals who will be joining us as #PGY1s in July! Please join us in welcoming them to the #UofT #Neurosurgery family!

[gelareh-zadeh @gelarehzadeh]

Wonderful to have everyone together from https://t.co/BZkJQwziqz
⁦@MayoClinicNeuro⁩ ⁦@MayoClinic⁩ #Gattle #Research #Symposium

I am the luckiest person to have such outstanding, amazing, talented, awe inspiring young people to work with & have as my #guiding #stars

[gelareh-zadeh @gelarehzadeh]

The many faces of #Love
I am blessed, lucky, fortunate, privileged & honored to have outstanding #student
@lsyefet @AndrewAjisebutu @chloegui_
@CNS_Update @cnsnews #CNS2025
Outstanding presentations & awards! Congratulations

[Chloe Gui @chloegui_]

Thank you for the shout out!!

[The Yang Lab @TheYangLab1]

Great talk on #TERT expression in #meningioma @chloegui_ @gelarehzadeh @UofT @ShermanMDneuro @RutgersNeuroDoc @BhuvicP @WashUNeurosurg @TumorSection @CNS_Update #2025cns #cns2025 #cnsconnects #LA @NeurosurgeryCNS @IsaacYangMD @UCLANsgy @UCLA_ENT @UCLAHealth @dgsomucla @HarborUCLA @HarborUCLASurg @HarborTrauma

[The Brain Tumour Charity @BrainTumourOrg]

Meningiomas are usually low-grade, but they sometimes behave more aggressively than doctors expect. The Charity is funding a growing body of research led by Dr Gelareh Zadeh to improve understanding of these tumours.

#BrainTumours #LowGrade #Meningioma

[Farshad Nassiri @FarshadNassiri]

Lots of fun chatting with Kat Gourd @TheLancetOncol about findings of joint papers on TERT in meningioma
@gelarehzadeh @chloegui_ @ICOMeningioma

submitted together with @wenyalindabi #MSnuderl and team.
Remembering K Groff

Looking forward to working on next steps together!

[Wenya Linda Bi @wenyalindabi]

Grateful to the many teams who supported this work, championed by Karenna Groff. As we uncover more biomarkers of tumor behavior, implementation into clinical practice merits close introspection of context. @MGBneurosurgery @LabRaleigh @sahm_lab @MGBCTNS @NYUneurosurgery @RuchitVP

[Mayo Clinic Neuro @MayoClinicNeuro]

A new multi-institutional study led by @MayoClinic neurosurgeon @gelarehzadeh, reveals that high activity in a gene called TERT can predict whether a tumor is more likely to recur quickly — even if it appears low-grade. https://t.co/0uLFtinkBR

[gelareh-zadeh @gelarehzadeh]

Appreciate & Proud to have @MayoClinic promote our discoveries #braintumor #meningioma research
Thanks goes to the outstanding #neurosurgery #scientists #collaborators that make these findings to #transform care possible
#team #science @ICOMeningioma @UHN
Above all #Patients 🙏🏽

[Farshad Nassiri @FarshadNassiri]

🚨New #pub @TheLancetOncol from our team @ICOMeningioma , led by ⭐️@chloegui_ ⭐️

In >1,200 #meningiomas, TERT expression—even without mutation—predicts early #recurrence, on par with a #WHO grade increase.

https://t.co/CNGDmFN6Ta

#NeuroOncology #Biomarker #PrecisionMedicine

[Mayo Clinic @MayoClinic]

New research led by a Mayo Clinic neurosurgeon showed that meningiomas with TERT activity act more aggressively than their grade suggests.

Learn more: https://t.co/wAxG5XHUr9

[gelareh-zadeh @gelarehzadeh]

1/ Our new publication @TheLancetOncol 🙏🏽
Ledy by @chloegui_ superstar #PhD #Neurosurgery @UofTNeuroSurge @UofTSurgery @uoftmedicine

Grateful to my amazing #team #science @justinzw @ap_landry @PatilVikas1010 @FarshadNassiri ++ more

[Krembil Brain Institute @KBI_UHN]

🎙️✨ Congratulations to Dr. @FarshadNassiri, neurosurgeon at UHN's Krembil Brain Institute and scientist at Princess Margaret Cancer Centre, on his recent podcast appearance hosted by @TheLancet Oncology!

🔗: https://t.co/gPmjzuTeAz

#NoResearchNoCure

[gelareh-zadeh @gelarehzadeh]

Grateful for support partnership & team work of our research made possible between multiple sites
@UHN @UHN_Research @PMResearch_UHN @UofTNeuroSurge @UofTSurgery @uoftmedicine
@MayoClinic @MayoClinicNeuro @MayoClinicSOM
🙏🏽 @TheLancetOncol
@ICOMeningioma

[Chloe Gui @chloegui_]

We found in a multi-institutional cohort >1200 tumours, over 30% of meningiomas expressed TERT (whereas only 3% had TERT promoter mutations). Patients with meningiomas that expressed TERT had PFS similar to those with meningiomas that were one WHO grade higher.

[Chloe Gui @chloegui_]

Excited to share our paper published in @TheLancetOncology showing #TERT expression (independent of mutation) is associated with earlier recurrence in #meningiomas. Thank you to my supervisors @GelarehZadeh @FarshadNassiri, coauthors, editors, reviewers https://t.co/bRlxwDdl2c

[University of Toronto Neurosurgery @UofTNeuroSurge]

We had the pleasure of hosting all first year neurosurgery residents from across Canada for the 14th Annual Canadian Neurosurgery Rookie Camp. A huge thank you to our dedicated faculty, residents, sponsors, and support teams who made this event possible. @uoftmedicine

[University of Toronto Neurosurgery @UofTNeuroSurge]

Our PGY1s, Bianka, Eddie, Sabra and Seika, just finished their crash course in neurosurgery! They are phenomenal and we are excited to see their journey in neurosurgery unfold.